Mares, a professor in the Department of Ophthalmology and Visual Sciences, retired from UW-Madison on July 14th after a lengthy career exploring the connections between food, a healthy lifestyle, genetics, and nutrition in preserving eye health.
Research News
UW Researchers Will Develop Gene Editing Therapy to Treat Blindness
A new study by UW researchers will test gene editing therapy to treat blindness. The collaborative project involves a team of ophthalmology researchers and biomedical engineers.
Introducing the 2023 Kambara Symposium Keynote Speaker: Shiming Chen
A highly accomplished vision scientist and expert in retinal disease will be the keynote speaker at the 2023 George Kambara, MD Vision Science Symposium on Friday, April 14.
New Nanoparticles Deliver Therapy Brain-Wide, Edit Alzheimer’s Gene In Mice
Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease.
Lab-Grown Retinal Eye Cells Open Door For Clinical Trials to Treat Blindness
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.
UW Researcher Receives Grant to Expand Knowledge of Molecules Regulating Retinal Function
Mrinalini Hoon, PhD, has been granted a $150,000 Research to Prevent Blindness (RPB) Career Advancement Award.
New Research May Shed Light on Impact of Toxic Metals on Aging Dogs
New research led by a University of Wisconsin–Madison assistant professor could shed some light on whether toxic metals commonly found in and around the home could impact an older dog’s vision and overall health.
UW-Madison Launches New Ophthalmology Tissue Biobank
The University of Wisconsin Department of Ophthalmology and Visual Sciences (DOVS) has entered into a new partnership aimed at systematically collecting, storing, processing and distributing human eye tissue for research purposes.
New nanoparticles aid sepsis treatment in mice
Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.